Paloma Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-10,858
Closed -$47K 1811
2016
Q4
$47K Buy
+10,858
New +$47K ﹤0.01% 1473
2016
Q3
Sell
-59,558
Closed -$337K 1806
2016
Q2
$337K Buy
+59,558
New +$337K ﹤0.01% 1284
2013
Q3
Sell
-41,037
Closed -$384K 1303
2013
Q2
$384K Buy
+41,037
New +$384K 0.02% 547